Cargando…
Combined treatment with endobronchial Watanabe spigot and N ‐butyl‐2‐cyanoacrylate for refractory pneumothorax in COVID‐19
Coronavirus disease 2019 (COVID‐19) causes pneumothorax or mediastinal emphysema in approximately 1% of patients. According to the British Thoracic Society guidelines, the next treatment option for patients with persistent pneumothorax despite chest drainage is pleurodesis or surgery. In fact, there...
Autores principales: | Morita, Chie, Kitamura, Atsushi, Okafuji, Kohei, Ro, Shosei, Imai, Ryosuke, Shirasaki, Kasumi, Watanabe, Yu, Nishimura, Naoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918464/ https://www.ncbi.nlm.nih.gov/pubmed/35309960 http://dx.doi.org/10.1002/rcr2.923 |
Ejemplares similares
-
Difficult removal after bronchial filling of an endobronchial Watanabe spigot with N‐butyl‐2‐cyanoacrylate for intractable pneumothorax: A case report
por: Nakamura, Tomoaki, et al.
Publicado: (2023) -
Spigot in pneumothorax cavity: A rare complication of endobronchial Watanabe spigot
por: Miyoshi, Shion, et al.
Publicado: (2021) -
Treatment of Intractable Pneumothorax with Emphysema Using Endobronchial Watanabe Spigots
por: Lee, Doo Yun, et al.
Publicado: (2013) -
Endobronchial embolization for life-threatening hemoptysis with Endobronchial Watanabe Spigot
por: Kho, Sze Shyang, et al.
Publicado: (2017) -
Utility of the endobronchial Watanabe spigot for intractable cancer-related pneumothorax: a retrospective observational study
por: Adachi, Masahiro, et al.
Publicado: (2023)